MeCo Diagnostics
Unlocking antifibrotic therapy for breast cancer and beyond…
9 employees · est. 2022 · San Diego, United States
Mural Oncology
Leveraging our protein engineering platform to improve cytokine-based immunotherapies for the treatment of #cancer
112 employees · est. 2023 · Waltham, United States
MeCo Diagnostics is the older company (2022 vs 2023); Mural Oncology is the larger of the two.
Side-by-Side Comparison
| Metric | MeCo Diagnostics | Mural Oncology |
|---|---|---|
| Founded | ||
| Founded | 2022 older | 2023 |
| Headquarters | ||
| Headquarters | San Diego, United States | Waltham, United States |
| Employees | ||
| Employees | 9 | 112 larger |
| Industry | ||
| Industry | Not tracked yet | Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Seed | Corporate Round |
| Total Funding | ||
| Total Funding | $500.00K | $275.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cancer, Biomarker Testing, Drug Repurposing, Antifibrotic Drugs, Metastasis Prevention, Clinical Studies, Neoadjuvant Treatments, Breast Cancer, Prostate Cancer, Drug Development, Generic Drugs, Cost-effective Therapy, Predictive Medicine, Healthcare Innovation, Startup | Immuno-oncology, Cytokine Biology, Cancer, Drug Discovery, Protein Engineering, Immunotherapy, Ovarian Cancer, Melanoma, Nemvaleukin Alfa, Interleukin-18, Interleukin-12, Immune Cell Modulation, Tumor-targeted Therapies, Public Company, Clinical Benefit |
| Website | ||
| Website | mecodiagnostics.com | muraloncology.com |
About MeCo Diagnostics
MeCo Diagnostics, founded in 2022, is a pioneering player in the Biotechnology and Medical Devices industry, headquartered in the United States. With the slogan "Unlocking antifibrotic therapy for breast cancer and beyond…", the company offers a clinically validated biomarker test that bridges patie...
About Mural Oncology
Mural Oncology, founded in 2023, is a healthcare startup based in the United States. The company focuses on leveraging its protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Their slogan, "Leveraging our protein engineering platform to improve c...
We will tell you when either one moves
BounceWatch watches MeCo Diagnostics and Mural Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at MeCo Diagnostics and Mural Oncology — by email.
Frequently Asked Questions
Compare MeCo Diagnostics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at MeCo Diagnostics on 11 Sep 2024, and Mural Oncology on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.